🔬ResearchFDA Issues Safety Warning Linking GLP-1 Medications to Rare Eye Condition
The U.S. Food and Drug Administration has issued a safety communication warning of a potential link between GLP-1 receptor agonists and a rare, permanent vision condition known as NAION.




